Quote | ADiTx Therapeutics Inc. (NASDAQ:ADTX)
Last: | $3.1699 |
---|---|
Change Percent: | 4.27% |
Open: | $3.0515 |
Close: | $3.04 |
High: | $3.2597 |
Low: | $3.05 |
Volume: | 82,491 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | ADiTx Therapeutics Inc. (NASDAQ:ADTX)
Aditxt (NASDAQ: ADTX) previously entered into a definitive agreement to acquire Evofem Biosciences Inc. (OTCQB: EVFM) , which is believed to represent a compelling opportunity to accelerate Evofem’s growth trajectory, as a subsidiary of Aditxt, into a multi-product women’s health ...
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 PR Newswire -- Third Consecutive Year of Phexxi Net Sales Growth -- -- Total Operating Expense Reduced 64% from 2022 Levels -- -- Sales and marketing expense as a percent...
Message Board Posts | ADiTx Therapeutics Inc. (NASDAQ:ADTX)
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: NetworkNewsBreaks Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome | NetworkNewsWire | investorshangout | 05/05/2023 8:26:16 PM |
NetworkNewsWire: Stem Cell Transplantation Shows Promise in Treating Autoimmune Disorders Data from | NetworkNewsWire | investorshangout | 05/03/2023 8:54:16 PM |
Benstoke: Bets For Home Improvement Success And Satisfaction You might have heard people tell you ho | Benstoke | investorshangout | 04/29/2023 3:46:54 PM |
NetworkNewsWire: Organ Donation, Transplantation: Challenges and How We Can Help More Individuals Na | NetworkNewsWire | investorshangout | 04/27/2023 9:03:02 PM |
NetworkNewsWire: NetworkNewsBreaks Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Off | NetworkNewsWire | investorshangout | 04/25/2023 8:04:37 PM |
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
Aditxt (NASDAQ: ADTX) previously entered into a definitive agreement to acquire Evofem Biosciences Inc. (OTCQB: EVFM) , which is believed to represent a compelling opportunity to accelerate Evofem’s growth trajectory, as a subsidiary of Aditxt, into a multi-product women’s health ...
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 PR Newswire -- Third Consecutive Year of Phexxi Net Sales Growth -- -- Total Operating Expense Reduced 64% from 2022 Levels -- -- Sales and marketing expense as a percent...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...